Navigation Links
Cone-Beam CT faster, potentially more accurate than conventional mammography
Date:12/27/2007

Cone-beam breast CT provides exceptional tissue contrast and can potentially reduce examination time with comparable radiation dose to conventional 2D mammography, according to a new study by a team of researchers from the University of Texas M. D. Anderson Cancer Center in Houston.

Cone-beam breast CT employs a large area x-ray beam in conjunction with a flat panel x-ray detector to scan and generate 3D images of the breast. The scanner is placed below a table on which the patient lies prone with the breast protruding through an opening. Only the breast is exposed to radiation resulting in improved image quality and sparing the rest of the patients body from unnecessary radiation exposure. The scan can be completed in less than one minute with a single complete rotation of the x-ray tube-detector gantry around the breast. Unlike conventional CT, the patient is not moved through the gantry during scanning.

For the study, the researchers used cone-beam CT on 12 mastectomy specimens. The researchers discovered that structured noise on cone-beam CT was minimal because of the absence of overlapping tissue; that breast anatomy was well resolved on all images as skin, adipose, and glandular regions; and that microcalcifications within cancers were clearly shown. In addition, they discovered that the detection of cancers based on morphologic assessment of tissue structures could potentially be improved compared with mammography because of the lack of overlapping glandular tissue.

Conventional 2D mammography is currently the most prevalent imaging technique for screening and diagnosis of breast cancers. However, the 2D projection images can overlap normal tissue, soft tissue masses, and calcifications and affect the detection and visualization of cancer. Despite the advantage of excellent spatial resolution, conventional mammography is unable to diagnose all cancers, especially early cancers in dense breasts, and cancers in high risk women such as genetic carriers, said Wei Tse Yang, MD, lead author of the study.

The researchers believe that cone-beam CT may potentially be used to replace mammography in screening and diagnostic breast imaging. In addition to overcoming the problem of overlapping breast tissue, cone-beam breast CT has the ability to provide true 3D images of the breast that may help depict the 3D morphology and distribution of lesions, and that may provide incremental benefit in the differentiation of abnormalities from background breast tissue. In addition, the multiplanar high-resolution surveys it provides are at a radiation dose comparable to routine mammography, said Dr. Yang.

Besides those benefits of cone-beam breast CT, the researchers pointed out others, as well. Scanning using this method takes less than one minute. This compares with 40 minutes for breast MRI, and 10 minutes for mammography. It also eliminates the discomfort associated with compression during mammography and the problem of claustrophobia during MRI, said Dr. Yang.

The full results of this study appear in the December issue of the American Journal of Roentgenology, published by the American Roentgen Ray Society.


'/>"/>
Contact: Necoya Tyson
necoya@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Related medicine news :

1. Regulatory Affairs Associates Gets New Drugs Tested Faster, Wins 2007 Innovation Michigan Award
2. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
3. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
4. Molecular profiling can accurately predict survival in colon cancer patients
5. PET scans can accurately detect a breast tumors response to chemotherapy
6. ADA Calls for Scientifically Accurate Patient Brochure Explaining Filling Choices
7. Dr. Laura Jana Offers Parents Five Key Ways to Ensure Accurate Dosing of Liquid Medication to Infants
8. CT angiography highly accurate, multicenter trials show
9. CT Angiography Highly Accurate: Multicenter Trials Show
10. Breaking Studies at AARC Congress Show Masimo SET and Masimo Rainbow SET to be Accurate, Effective and Uniquely Beneficial in Detecting and Tracking Disease States
11. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, ... families throughout the Five Boroughs, is launching a charity drive to raise funds that ... the traditions and spirit of marines and Navy FMF Corpsmen. Working closely with the ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... December 07, 2016 , ... The medical profession is well aware that heart ... major study analyzing heart attacks among 138,602 people recorded a 35% higher number of ... would all agree of course–no time of year is a good time for a ...
(Date:12/7/2016)... Norwalk, CT (PRWEB) , ... December 07, 2016 ... ... the Integrated Infertility and Wellness (IFW) Program at Reproductive Medicine Associates of Connecticut ... which now has a team of three acupuncturists to help patients realize their ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016 According to responses from ... than one-third (38%) of patients with non-small cell lung cancer ... factor receptor (EGFR) genetic mutation status. The findings of the ... LBA ID #6067 #P3.02b ) at the 2016 World ... . The survey results revealed an overall ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 ... II trial in patients with unresectable malignant pleural ... survival (PFS). The data, presented at the 17 ... in Vienna , showed nintedanib ... to placebo plus pemetrexed/cisplatin, with a significantly improved ...
(Date:12/7/2016)... Today, Stock-Callers.com presents four Biotech equities ... ), Anthera Pharmaceuticals Inc. (NASDAQ: ANTH ), ProNAi ... (NASDAQ: AVXS ). From its peak in July ... reach a level equal to what it saw at the ... for the year, it has still out-performed other market sectors, ...
Breaking Medicine Technology: